RecruitingPhase 2

Oral NSAI Versus Acetaminophen or Placebo as a Discharge Treatment of Non Complicated Renal Colics

Tunisia500 participantsStarted 2023-07-01

Plain-language summary

Treatment with NSAI in renal colics has not been well investigated and there is no clear recommendations regarding this subject. The aim of this study is to determine if an oral NSAI treatment is beneficial in patients discharged for the emergency department after the first line treatment of a renal colic investigating the reccurence of pain, the reconsultation rates and the admissions.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Over 18 years old * Consenting to participate in the study * Patients treated in the ED for RC * No contraindications of NSAI or paracetamol treatment Exclusion Criteria: * Contraindication of NSAI treatment * Patients non reachable by telephone call * Patients that did not receive or use the treatment

What they're measuring

Efficacity of oral NSAI

Timeframe: 07 days

Trial details

NCT IDNCT05722782

SponsorUniversity of Monastir

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-06

Contact for this trial

Nouira semir, MD

73106000 semir.nouira@rns.tn

View on ClinicalTrials.gov More Renal Colic trials